Pitcairn CO Edwards Lifesciences Corp Transaction History

Pitcairn CO

$1.24 Billion
Q3 2025

A detailed history of Pitcairn CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pitcairn CO holds 10,319 shares of EW stock, worth $890,529. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,319

Previous 11,685 11.69%

Holding current value

$890,529

Previous $913,000 12.16%

% of portfolio

0.06%

Previous 0.06%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$73.75 - $81.83 $100,742 - $111,779	-1,366 Reduced 11.69%	10,319 $802,000
Q2 2025 Aug 14, 2025	SELL	$67.07 - $78.22 $186,722 - $217,764	-2,784 Reduced 19.24%	11,685 $913,000
Q1 2025 May 09, 2025	SELL	$67.95 - $76.19 $37,780 - $42,361	-556 Reduced 3.7%	14,469 $1.05 Million
Q4 2024 Feb 12, 2025	SELL	$64.54 - $75.92 $495,344 - $582,686	-7,675 Reduced 33.81%	15,025 $1.11 Million
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $2.15 Million - $3.37 Million	-35,970 Reduced 61.31%	22,700 $1.5 Million

Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $266,050 - $297,642	3,156 Added 5.69%	58,670 $5.42 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $291,900 - $384,533	-4,024 Reduced 6.76%	55,514 $5.3 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $460,973 - $580,867	7,470 Added 14.35%	59,538 $4.54 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $22,100 - $29,788	319 Added 0.62%	52,068 $3.61 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $68,628 - $79,520	843 Added 1.66%	51,749 $4.88 Million
Q1 2023 May 05, 2023	BUY	$74.26 - $84.51 $179,709 - $204,514	2,420 Added 4.99%	50,906 $4.21 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $145,342 - $186,072	-2,128 Reduced 4.2%	48,486 $3.62 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $40,773 - $53,108	495 Added 0.99%	50,614 $4.18 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $144,801 - $214,723	1,674 Added 3.46%	50,119 $4.77 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $9,176 - $11,550	-90 Reduced 0.19%	48,445 $5.7 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $3,191 - $3,920	30 Added 0.06%	48,535 $6.29 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $247,601 - $295,336	-2,406 Reduced 4.73%	48,505 $5.49 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $84,846 - $106,017	-1,012 Reduced 1.95%	50,911 $5.27 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $60,583 - $69,815	770 Added 1.51%	51,923 $4.34 Million
Q4 2020 Feb 05, 2021	SELL	$71.69 - $91.23 $79,862 - $101,630	-1,114 Reduced 2.13%	51,153 $4.67 Million
Q3 2020 Nov 03, 2020	BUY	$67.19 - $87.44 $20,694 - $26,931	308 Added 0.59%	52,267 $4.17 Million
Q2 2020 Jul 28, 2020	BUY	$57.54 - $76.95 $1.97 Million - $2.63 Million	34,220 Added 192.91%	51,959 $3.59 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $90,197 - $139,401	-1,721 Reduced 8.84%	17,739 $3.35 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $30,257 - $34,641	422 Added 2.22%	19,460 $4.54 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $17,357 - $21,271	282 Added 1.5%	19,038 $4.19 Million
Q2 2019 Aug 12, 2019	BUY	$55.74 - $64.41 $2,842 - $3,284	51 Added 0.27%	18,756 $3.47 Million
Q1 2019 May 07, 2019	SELL	$47.89 - $64.05 $32,660 - $43,682	-682 Reduced 3.52%	18,705 $3.58 Million
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $63,767 - $78,235	-1,374 Reduced 6.62%	19,387 $2.97 Million
Q3 2018 Nov 02, 2018	BUY	$45.7 - $58.03 $114,889 - $145,887	2,514 Added 13.78%	20,761 $3.61 Million
Q2 2018 Aug 02, 2018	BUY	$42.45 - $51.3 $95,088 - $114,912	2,240 Added 13.99%	18,247 $2.66 Million
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $42,322 - $53,998	-1,138 Reduced 6.64%	16,007 $2.23 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $17,976 - $20,955	-532 Reduced 3.01%	17,145 $1.93 Million
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $641,498 - $686,397	17,677	17,677 $1.93 Million

Others Institutions Holding EW

# of Institutions

1,471

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account